Gianutsos G, Morrow G, Light S, Sweeney M J
Pharmacol Biochem Behav. 1982 Nov;17(5):951-4. doi: 10.1016/0091-3057(82)90478-6.
Nomifensine and a proposed dihydroxy metabolite produced stimulation of motor behavior in mice with nomifensine being more potent. Weak cage-climbing behavior (stereotypy) was also produced. The stimulatory effects were greater in mice in which dopamine receptor sensitivity was increased by long-term haloperidol. Both of the analogs were potent inhibitors of dopamine and norepinephrine uptake in vitro with nomifensine approximately 3 times more potent than the metabolite. In contrast, the two analogs had weak affinity for the post-synaptic dopamine receptor (as measured by displacement of ligand binding in vitro) with dihydroxynomifensine approximately 6 times more potent than nomifensine. These results suggest that the behavioral effects of nomifensine are largely dependent on presynaptic catecholamine mechanisms but that weak direct dopamine agonist properties do exist, particularly in vivo where the drug may be metabolized to a more active form.
去甲丙咪嗪及其一种推测的二羟基代谢产物可刺激小鼠的运动行为,且去甲丙咪嗪的作用更强。还会产生轻微的笼内攀爬行为(刻板行为)。在长期使用氟哌啶醇使多巴胺受体敏感性增加的小鼠中,刺激作用更强。这两种类似物在体外都是多巴胺和去甲肾上腺素摄取的强效抑制剂,去甲丙咪嗪的效力约为代谢产物的3倍。相比之下,这两种类似物对突触后多巴胺受体的亲和力较弱(通过体外配体结合置换来测定),二羟基去甲丙咪嗪的效力约为去甲丙咪嗪的6倍。这些结果表明,去甲丙咪嗪的行为效应很大程度上依赖于突触前儿茶酚胺机制,但确实存在较弱的直接多巴胺激动剂特性,尤其是在体内,药物可能会代谢为更具活性的形式。